Daniel O Persky (Daniel Persky)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Topics

Clinical Practice

Chronic Lymphocytic Leukemia

Tyrosine Kinase

Diffuse Large B Cell Lymphoma

Top Venues

Cancer research communications

British journal of haematology

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T Williams, Banmeet S Anand, Jack P Higgins, Daniel O Persky
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer research communications 2 (5) (2022)
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack, Eric T Williams, Banmeet S Anand, Jack P Higgins, Daniel O Persky
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma. Cancer research communications 2 (5) (2022)
Max J Gordon, Andy Kaempf, Andrea Sitlinger, Geoffrey Shouse, Matthew G Mei, Danielle M Brander, Tareq Salous, Brian T Hill, Hamood Alqahtani, Michael Choi, Michael C Churnetski, Jonathon B Cohen, Deborah M Stephens, Tanya Siddiqi, Xavier Rivera, Daniel O Persky, Paul Wisniewski, Krish Patel, Mazyar Shadman, Byung S Park, Alexey V Danilov
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Nicole A Carreau, Philippe Armand, Reid W Merryman, Ranjana H Advani, Michael A Spinner, Alex F Herrera, Radhakrishnan Ramchandren, Muhammad S Hamid, Sarit Assouline, Raoul Santiago, Nina Wagner-Johnston, Suman Paul, Jakub Svoboda, Steven M Bair, Stefan K Barta, Sunita Nathan, Reem Karmali, Pallawi Torka, Kevin David, Frederick Lansigan, Daniel O Persky, James Godfrey, Julio C Chavez, Yuhe Xia, Catherine S Diefenbach
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy. British journal of haematology 191 (1) (2020)
Alexey V Danilov, Daniel O Persky
Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies. British journal of haematology 193 (1) (2020)
Daniel O Persky
Limited-stage DLBCL: it's patient selection. Blood 131 (2) (2019)
Daniel O Persky, Hongli Li, Lisa M Rimsza, Paul M Barr, Leslie L Popplewell, Charles L Bane, Ann Von Gehr, Michael LeBlanc, Richard I Fisher, Sonali M Smith, Jonathan W Friedberg
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806. American journal of hematology 93 (4) (2018)